Balance Sheet Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 10:28:16 16/07/2025 am IST			5-day change	1st Jan Change
2,626.00 ^INR	-0.94%		+3.89%	-8.87%

11/07	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR2,870, Keeps at Buy	MT
30/06	India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma	RE

b5e8a0ccfa5e788a9d3.Mky5Upt8HJjNKV-X4IDPsL4fUfc9kJXH15NZXFMDVwo.ZjzQY8oQWfn6G2fdq82q9vl0Nqh-58-As-YBMxVLG1tgAP0cyx0srKYEBg

Published financial data: MANKIND PHARMA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	5.87TCr	6.22TCr	7.78TCr	8.75TCr	10TCr
Total Revenues	5.87TCr	6.22TCr	7.78TCr	8.75TCr	10TCr
Cost of Goods Sold, Total	1.92TCr	1.85TCr	2.49TCr	3TCr	3.32TCr
Gross Profit	3.95TCr	4.38TCr	5.29TCr	5.75TCr	7.01TCr
Selling General & Admin Expenses, Total	1.61TCr	1.81TCr	2.09TCr	2.31TCr	2.9TCr
Depreciation & Amortization - (IS)	99Cr	118.97Cr	166.62Cr	325.92Cr	398.25Cr
Other Operating Expenses	772.18Cr	860.39Cr	1.16TCr	1.52TCr	1.56TCr
Other Operating Expenses, Total	2.48TCr	2.79TCr	3.42TCr	4.16TCr	4.86TCr
Operating Income	1.47TCr	1.59TCr	1.88TCr	1.59TCr	2.15TCr
Interest Expense, Total	-22Cr	-19Cr	-56Cr	-40Cr	-29Cr
Interest And Investment Income	17Cr	39Cr	13Cr	13Cr	40Cr
Net Interest Expenses	-4.37Cr	19Cr	-43Cr	-28Cr	11Cr
Income (Loss) On Equity Invest.	12Cr	12Cr	14Cr	12Cr	15Cr
Currency Exchange Gains (Loss)	-1.02Cr	50.24L	8.84Cr	10Cr	8.64Cr
Other Non Operating Income (Expenses)	4.94Cr	5.06Cr	3.31Cr	54Cr	88Cr
EBT, Excl. Unusual Items	1.48TCr	1.63TCr	1.86TCr	1.64TCr	2.27TCr
Impairment of Goodwill	-	-	-	-3.85Cr	-
Gain (Loss) On Sale Of Investments	35Cr	63Cr	112.95Cr	37Cr	129.53Cr
Gain (Loss) On Sale Of Assets	11Cr	-3.04Cr	-3.74Cr	1.66Cr	48.01L
Asset Writedown	-91Cr	-3.89Cr	-5.76Cr	-9.71Cr	-9.16Cr
Insurance Settlements	66.61L	93.68L	1.36Cr	4.31Cr	1.07Cr
Other Unusual Items	-	7.71Cr	8.53Cr	4.15Cr	2.48Cr
EBT, Incl. Unusual Items	1.44TCr	1.69TCr	1.97TCr	1.67TCr	2.4TCr
Income Tax Expense	381.59Cr	398.58Cr	521.64Cr	361.56Cr	457.59Cr
Earnings From Continuing Operations	1.06TCr	1.29TCr	1.45TCr	1.31TCr	1.94TCr
Net Income to Company	1.06TCr	1.29TCr	1.45TCr	1.31TCr	1.94TCr
Minority Interest	-26Cr	-28Cr	-19Cr	-28Cr	-29Cr
Net Income - (IS)	1.03TCr	1.27TCr	1.43TCr	1.28TCr	1.91TCr
Net Income to Common Incl Extra Items	1.03TCr	1.27TCr	1.43TCr	1.28TCr	1.91TCr
Net Income to Common Excl. Extra Items	1.03TCr	1.27TCr	1.43TCr	1.28TCr	1.91TCr
Per Share Items
Net EPS - Basic	25.72	31.59	35.78	32	47.75
Basic EPS - Continuing Operations	25.72	31.59	35.78	32	47.75
Basic Weighted Average Shares Outstanding	40Cr	40Cr	40Cr	40Cr	40Cr
Net EPS - Diluted	25.72	31.59	35.78	32	47.68
Diluted EPS - Continuing Operations	25.72	31.59	35.78	32	47.68
Diluted Weighted Average Shares Outstanding	40Cr	40Cr	40Cr	40Cr	40Cr
Normalized Basic EPS	22.47	24.7	28.55	24.85	34.77
Normalized Diluted EPS	22.47	24.7	28.55	24.85	34.72
Dividend Per Share	3.1	-	-	-	-
Payout Ratio	29.35	-	-	-	-
Supplemental Items
EBITDA	1.57TCr	1.7TCr	2.04TCr	1.91TCr	2.54TCr
EBITA	1.48TCr	1.6TCr	1.9TCr	1.74TCr	2.31TCr
EBIT	1.47TCr	1.59TCr	1.88TCr	1.59TCr	2.15TCr
EBITDAR	1.58TCr	1.72TCr	2.06TCr	1.93TCr	2.56TCr
Total Revenues (As Reported)	5.98TCr	6.39TCr	7.98TCr	8.88TCr	11TCr
Effective Tax Rate - (Ratio)	26.54	23.56	26.42	21.63	19.07
Total Current Taxes	408.4Cr	394.74Cr	469.03Cr	327.56Cr	492.58Cr
Total Deferred Taxes	-33Cr	2.42Cr	53Cr	34Cr	-35Cr
Normalized Net Income	900.3Cr	989.29Cr	1.14TCr	995.46Cr	1.39TCr
Interest on Long-Term Debt	25.38L	32.71L	47.95L	44.92L	78.51L
Non-Cash Pension Expense	3.51Cr	3.78Cr	4.12Cr	5.23Cr	6.56Cr
Supplemental Operating Expense Items
Advertising Expense	255.33Cr	373.38Cr	451.57Cr	373.67Cr	603.89Cr
Selling and Marketing Expenses	255.33Cr	373.38Cr	451.57Cr	373.67Cr	603.89Cr
Research And Development Expense From Footnotes	127.21Cr	12Cr	-	25Cr	25Cr
Net Rental Expense, Total	17Cr	18Cr	21Cr	20Cr	23Cr
Imputed Operating Lease Interest Expense	15Cr	13Cr	16Cr	12Cr	28Cr
Imputed Operating Lease Depreciation	2.53Cr	4.57Cr	4.95Cr	7.94Cr	-4.92Cr
Maintenance & Repair Expenses, Total	44Cr	49Cr	66Cr	89Cr	111.03Cr
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	6L	23Cr
Total Stock-Based Compensation	-	-	-	6L	23Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	226.08Cr	167.18Cr	302.53Cr	304.82Cr	382.01Cr
Short Term Investments	193.8Cr	533.56Cr	102.31Cr	141.31Cr	746.38Cr
Trading Asset Securities, Total	665.03Cr	1.31TCr	861.47Cr	1.08TCr	2.26TCr
Total Cash And Short Term Investments	1.08TCr	2.01TCr	1.27TCr	1.52TCr	3.39TCr
Accounts Receivable, Total	531.09Cr	330.61Cr	388.17Cr	576.42Cr	848.28Cr
Other Receivables	65.78L	69Cr	35Cr	32Cr	44Cr
Notes Receivable	34Cr	18Cr	1.19Cr	1.63Cr	2.86Cr
Total Receivables	566.25Cr	418.3Cr	423.99Cr	610.16Cr	894.96Cr
Inventory	899.13Cr	1.18TCr	1.76TCr	1.5TCr	1.55TCr
Prepaid Expenses	9.5Cr	37Cr	136.01Cr	33Cr	60Cr
Other Current Assets, Total	262.42Cr	260.94Cr	820.27Cr	664.49Cr	672.92Cr
Total Current Assets	2.82TCr	3.91TCr	4.41TCr	4.33TCr	6.57TCr
Gross Property Plant And Equipment	2.22TCr	2.44TCr	2.97TCr	3.76TCr	4.1TCr
Accumulated Depreciation	-351.51Cr	-444.77Cr	-582.24Cr	-743.73Cr	-963.39Cr
Net Property Plant And Equipment	1.86TCr	1.99TCr	2.39TCr	3.02TCr	3.14TCr
Long-term Investments	164.39Cr	209.73Cr	240.39Cr	357.76Cr	311.06Cr
Goodwill	20Cr	20Cr	20Cr	20Cr	20Cr
Other Intangibles, Total	26Cr	19Cr	1.87TCr	1.76TCr	1.66TCr
Loans Receivable Long-Term	10L	7L	3L	-	-
Deferred Tax Assets Long-Term	48Cr	49Cr	39Cr	30Cr	80Cr
Other Long-Term Assets, Total	127.65Cr	176.28Cr	176.97Cr	204.61Cr	181.82Cr
Total Assets	5.07TCr	6.37TCr	9.15TCr	9.72TCr	12TCr
Liabilities
Accounts Payable, Total	745.11Cr	666.96Cr	1.08TCr	1.01TCr	1.1TCr
Accrued Expenses, Total	88Cr	128.67Cr	259.77Cr	171.02Cr	222.78Cr
Short-term Borrowings	47Cr	197.55Cr	805.15Cr	115.02Cr	151.47Cr
Current Portion of Long-Term Debt	24Cr	19Cr	24Cr	24Cr	20Cr
Current Portion of Leases	1.14Cr	1.62Cr	2.06Cr	2.56Cr	3.42Cr
Current Income Taxes Payable	66Cr	11Cr	15Cr	46Cr	46Cr
Unearned Revenue Current, Total	4.31Cr	14Cr	19Cr	166.23Cr	185.85Cr
Other Current Liabilities	275.48Cr	315.24Cr	421.37Cr	329.4Cr	387.13Cr
Total Current Liabilities	1.25TCr	1.35TCr	2.62TCr	1.86TCr	2.12TCr
Long-Term Debt	58Cr	57Cr	49Cr	23Cr	25Cr
Long-Term Leases	2.83Cr	4.51Cr	2.99Cr	5.18Cr	7.71Cr
Unearned Revenue Non Current	18Cr	7.89Cr	20Cr	25Cr	23Cr
Pension & Other Post Retirement Benefits	63Cr	72Cr	80Cr	98Cr	123.12Cr
Deferred Tax Liability Non Current	8.17Cr	13Cr	56Cr	77Cr	89Cr
Other Non Current Liabilities	1Cr	1Cr	-	-	-
Total Liabilities	1.4TCr	1.51TCr	2.83TCr	2.09TCr	2.39TCr
Common Stock, Total	40Cr	40Cr	40Cr	40Cr	40Cr
Additional Paid In Capital	42Cr	42Cr	42Cr	42Cr	42Cr
Retained Earnings	4.3TCr	5.54TCr	6.97TCr	8.25TCr	10TCr
Comprehensive Income and Other	-900.07Cr	-901.42Cr	-899.87Cr	-896.9Cr	-875.67Cr
Total Common Equity	3.49TCr	4.72TCr	6.16TCr	7.44TCr	9.36TCr
Minority Interest	186.26Cr	140.89Cr	161.08Cr	188.07Cr	212.7Cr
Total Equity	3.67TCr	4.86TCr	6.32TCr	7.62TCr	9.58TCr
Total Liabilities And Equity	5.07TCr	6.37TCr	9.15TCr	9.72TCr	12TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40Cr	40Cr	40Cr	40Cr	40Cr
ECS Total Common Shares Outstanding	40Cr	40Cr	40Cr	40Cr	40Cr
Book Value / Share	87	117.88	153.65	185.61	233.73
Tangible Book Value	3.44TCr	4.68TCr	4.26TCr	5.66TCr	7.68TCr
Tangible Book Value Per Share	85.85	116.9	106.36	141.21	191.72
Total Debt	133.46Cr	279.61Cr	883.64Cr	170.37Cr	207.17Cr
Net Debt	-951.45Cr	-1.73TCr	-382.68Cr	-1.35TCr	-3.18TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	63Cr	73Cr	81Cr	99Cr	124.03Cr
Debt Equivalent Oper. Leases	138.81Cr	143.48Cr	170.06Cr	163.41Cr	185.7Cr
Minority Interest, Total (Incl. Fin. Div)	186.26Cr	140.89Cr	161.08Cr	188.07Cr	212.7Cr
Equity Method Investments, Total	164.38Cr	165.79Cr	167.74Cr	181.41Cr	189.28Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	249.95Cr	284.47Cr	399.81Cr	417.08Cr	410.76Cr
Inventories - Work In Process, Total	72Cr	73Cr	94Cr	86Cr	100Cr
Inventories - Finished Goods, Total	525.65Cr	771.43Cr	1.2TCr	919.76Cr	1TCr
Inventories - Others	52Cr	54Cr	66Cr	76Cr	42Cr
Land - (BS)	241.75Cr	241.42Cr	243.48Cr	352.79Cr	352.99Cr
Buildings, Total	555.46Cr	575.01Cr	586.27Cr	1.05TCr	1.25TCr
Machinery, Total	1.05TCr	1.18TCr	1.39TCr	1.74TCr	2.15TCr
Full Time Employees	16.27T	17.4T	-	18.47T	19.54T
Accumulated Allowance for Doubtful Accounts (Supple)	4.27Cr	4.47Cr	11Cr	20Cr	28Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	1.03TCr	1.27TCr	1.43TCr	1.28TCr	1.91TCr
Depreciation & Amortization - CF	91Cr	104.88Cr	141.4Cr	167.08Cr	235.87Cr
Amortization of Goodwill and Intangible Assets - (CF)	5.57Cr	11Cr	20Cr	153.73Cr	153.65Cr
Depreciation & Amortization, Total	96Cr	115.44Cr	161.64Cr	320.81Cr	389.52Cr
Amortization of Deferred Charges, Total - (CF)	2.76Cr	3.53Cr	4.98Cr	5.11Cr	8.73Cr
(Gain) Loss From Sale Of Asset	-11Cr	3.04Cr	3.74Cr	-1.66Cr	-48.01L
(Gain) Loss on Sale of Investments - (CF)	-35Cr	-45Cr	-104.95Cr	-37Cr	-133.53Cr
Asset Writedown & Restructuring Costs	91Cr	-	-2.24Cr	14Cr	9.16Cr
Provision for Credit Losses	5.18Cr	1.49Cr	3.03Cr	1.94Cr	4Cr
(Income) Loss On Equity Investments - (CF)	-12Cr	-12Cr	-14Cr	-12Cr	-15Cr
Stock-Based Compensation (CF)	-	-	-	6L	23Cr
Provision and Write-off of Bad Debts	1.35Cr	75.41L	12Cr	14Cr	14Cr
Other Operating Activities, Total	43Cr	-98Cr	9.12Cr	61Cr	-80Cr
Change In Accounts Receivable	-308.83Cr	198.87Cr	-66Cr	-205.31Cr	-289.91Cr
Change In Inventories	-78Cr	-284.4Cr	-576.7Cr	261.78Cr	-55Cr
Change In Accounts Payable	183.14Cr	-78Cr	419.85Cr	-65Cr	97Cr
Change in Other Net Operating Assets	88Cr	99Cr	-363.32Cr	175.28Cr	267.88Cr
Cash from Operations	1.1TCr	1.17TCr	919.78Cr	1.81TCr	2.15TCr
Capital Expenditure	-227.97Cr	-308.43Cr	-464.86Cr	-789.02Cr	-315.33Cr
Sale of Property, Plant, and Equipment	11Cr	74.25L	3.15Cr	6.05Cr	7.51Cr
Cash Acquisitions	-	-	-	-3.83Cr	-
Sale (Purchase) of Real Estate properties	14Cr	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-1.88TCr	-43Cr	-67Cr
Investment in Marketable and Equity Securities, Total	-250.59Cr	-947.76Cr	943.04Cr	-236.64Cr	-1.74TCr
Net (Increase) Decrease in Loans Originated / Sold - Investing	23.35L	-31.86L	-10L	-40.94L	-
Other Investing Activities, Total	14Cr	37Cr	30Cr	13Cr	32Cr
Cash from Investing	-439.15Cr	-1.22TCr	-1.37TCr	-1.05TCr	-2.08TCr
Short Term Debt Issued, Total	14Cr	126.78Cr	1.27TCr	1.09TCr	374.61Cr
Long-Term Debt Issued, Total	37Cr	452.16Cr	5.86Cr	3.85Cr	26Cr
Total Debt Issued	50Cr	578.94Cr	1.28TCr	1.1TCr	400.7Cr
Short Term Debt Repaid, Total	-211.06Cr	-12Cr	-645.35Cr	-1.76TCr	-339.81Cr
Long-Term Debt Repaid, Total	-4.59Cr	-460.32Cr	-10Cr	-32Cr	-29Cr
Total Debt Repaid	-215.65Cr	-472.78Cr	-655.78Cr	-1.8TCr	-369.27Cr
Common Dividends Paid	-302.44Cr	-	-	-	-
Common & Preferred Stock Dividends Paid	-302.44Cr	-	-	-	-
Other Financing Activities, Total	-84Cr	-17Cr	-18Cr	-42Cr	-26Cr
Cash from Financing	-551.41Cr	89Cr	604.62Cr	-739.73Cr	5.27Cr
Foreign Exchange Rate Adjustments	3.6Cr	37.52L	47.79L	2.32Cr	1.17Cr
Miscellaneous Cash Flow Adjustments	-	-100.06Cr	1T	-	-
Net Change in Cash	109.68Cr	-59Cr	155.73Cr	22Cr	77Cr
Supplemental Items
Cash Interest Paid	22Cr	17Cr	18Cr	42Cr	26Cr
Cash Income Tax Paid (Refund)	330.91Cr	454.08Cr	499.51Cr	323.1Cr	479.53Cr
Levered Free Cash Flow	752.61Cr	587.71Cr	-1.62TCr	711.74Cr	1.21TCr
Unlevered Free Cash Flow	766.07Cr	599.73Cr	-1.59TCr	736.91Cr	1.23TCr
Change In Net Working Capital	24Cr	204.75Cr	582.3Cr	-250.32Cr	151.41Cr
Net Debt Issued / Repaid	-165.17Cr	106.16Cr	622.41Cr	-697.8Cr	31Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	20.01	17.37	15.12	10.52	12.41
Return on Total Capital	26.05	22.22	19.01	13.24	15.3
Return On Equity %	31.75	30.3	25.99	18.79	22.58
Return on Common Equity	32.67	30.84	26.36	18.86	22.77
Margin Analysis
Gross Profit Margin %	67.27	70.32	68.03	65.68	67.87
SG&A Margin	27.39	29.03	26.9	26.43	28.08
EBITDA Margin %	26.66	27.38	26.17	21.77	24.54
EBITA Margin %	25.14	25.72	24.39	19.91	22.31
EBIT Margin %	25.04	25.55	24.13	18.15	20.82
Income From Continuing Operations Margin %	17.99	20.78	18.67	14.97	18.79
Net Income Margin %	17.55	20.33	18.42	14.65	18.51
Net Avail. For Common Margin %	17.55	20.33	18.42	14.65	18.51
Normalized Net Income Margin	15.33	15.89	14.7	11.38	13.48
Levered Free Cash Flow Margin	12.82	9.44	-20.85	8.13	11.75
Unlevered Free Cash Flow Margin	13.05	9.64	-20.4	8.42	11.93
Asset Turnover
Asset Turnover	1.28	1.09	1	0.93	0.95
Fixed Assets Turnover	3.31	3.23	3.55	3.24	3.36
Receivables Turnover (Average Receivables)	15.63	14.45	21.65	18.14	14.51
Inventory Turnover (Average Inventory)	2.23	1.77	1.69	1.84	2.18
Short Term Liquidity
Current Ratio	2.26	2.89	1.68	2.32	3.1
Quick Ratio	1.29	1.78	0.64	1.14	2.02
Operating Cash Flow to Current Liabilities	0.88	0.86	0.35	0.97	1.02
Days Sales Outstanding (Average Receivables)	23.41	25.27	16.86	20.12	25.23
Days Outstanding Inventory (Average Inventory)	163.79	205.77	215.94	198.03	168.19
Average Days Payable Outstanding	119.6	120.9	103.82	138.78	114.45
Cash Conversion Cycle (Average Days)	67.61	110.14	128.98	79.37	78.97
Long Term Solvency
Total Debt/Equity	3.63	5.75	13.99	2.23	2.16
Total Debt / Total Capital	3.51	5.44	12.27	2.19	2.12
LT Debt/Equity	1.66	1.27	0.83	0.37	0.34
Long-Term Debt / Total Capital	1.6	1.2	0.72	0.36	0.33
Total Liabilities / Total Assets	27.63	23.69	30.95	21.53	19.96
EBIT / Interest Expense	68.24	82.67	33.66	39.44	75.24
EBITDA / Interest Expense	72.7	88.67	36.56	47.4	88.86
(EBITDA - Capex) / Interest Expense	62.13	72.64	28.22	27.81	77.83
Total Debt / EBITDA	0.09	0.16	0.43	0.09	0.08
Net Debt / EBITDA	-0.61	-1.01	-0.19	-0.71	-1.25
Total Debt / (EBITDA - Capex)	0.1	0.2	0.56	0.15	0.09
Net Debt / (EBITDA - Capex)	-0.71	-1.24	-0.24	-1.21	-1.43
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.91	6	25.22	12.44	18.12
Gross Profit, 1 Yr. Growth %	22.35	10.8	21.21	8.55	22.06
EBITDA, 1 Yr. Growth %	67.31	8.84	19.51	-4.31	33.15
EBITA, 1 Yr. Growth %	69.66	8.45	18.55	-5.96	32.34
EBIT, 1 Yr. Growth %	69.14	8.14	18.06	-13.32	35.48
Earnings From Cont. Operations, 1 Yr. Growth %	73	22.43	12.37	-9.86	48.26
Net Income, 1 Yr. Growth %	78.11	22.81	13.28	-10.58	49.23
Normalized Net Income, 1 Yr. Growth %	81.3	9.88	15.62	-12.97	39.93
Diluted EPS Before Extra, 1 Yr. Growth %	78.12	22.82	13.27	-10.57	49
Accounts Receivable, 1 Yr. Growth %	141.17	-37.75	17.41	48.5	47.16
Inventory, 1 Yr. Growth %	9.52	31.63	48.73	-14.87	3.67
Net Property, Plant and Equip., 1 Yr. Growth %	11.06	6.82	19.98	26.26	4.03
Total Assets, 1 Yr. Growth %	23.36	25.61	43.55	6.21	23.14
Tangible Book Value, 1 Yr. Growth %	23.94	36.17	-9.02	32.77	35.77
Common Equity, 1 Yr. Growth %	23.46	35.48	30.35	20.8	25.93
Cash From Operations, 1 Yr. Growth %	82.66	9.1	-19.12	97.15	18.7
Capital Expenditures, 1 Yr. Growth %	-23.42	35.29	52.21	69.73	-60.03
Levered Free Cash Flow, 1 Yr. Growth %	-	-21.91	-379.11	-143.45	70.67
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-21.71	-367.56	-145.97	67.26
Dividend Per Share, 1 Yr. Growth %	-30.34	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	11.79	15.12	18.66	15.24
Gross Profit, 2 Yr. CAGR %	-	16.44	15.77	14.71	15.11
EBITDA, 2 Yr. CAGR %	-	34.95	14.05	5.74	12.87
EBITA, 2 Yr. CAGR %	-	35.65	13.39	4.32	11.56
EBIT, 2 Yr. CAGR %	-	35.24	12.99	-0.06	8.37
Earnings From Cont. Operations, 2 Yr. CAGR %	-	45.54	17.29	0.64	15.6
Net Income, 2 Yr. CAGR %	-	47.9	17.95	0.65	15.52
Normalized Net Income, 2 Yr. CAGR %	-	41.15	12.72	0.31	10.36
Diluted EPS Before Extra, 2 Yr. CAGR %	-	47.91	17.95	0.65	15.44
Accounts Receivable, 2 Yr. CAGR %	-	22.53	-14.51	32.04	47.83
Inventory, 2 Yr. CAGR %	-	20.07	39.92	12.52	-6.06
Net Property, Plant and Equip., 2 Yr. CAGR %	-	8.92	13.21	23.08	14.61
Total Assets, 2 Yr. CAGR %	-	24.48	34.28	23.47	14.36
Tangible Book Value, 2 Yr. CAGR %	-	29.91	11.31	9.91	34.26
Common Equity, 2 Yr. CAGR %	-	29.33	32.89	25.48	23.34
Cash From Operations, 2 Yr. CAGR %	-	39.58	-7.38	26.27	52.98
Capital Expenditures, 2 Yr. CAGR %	-	1.79	42.8	60.73	-17.64
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	46.83	10.65	-13.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	43.96	11.44	-12.31
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	16.04	14.22	18.48
Gross Profit, 3 Yr. CAGR %	-	-	17.92	13.31	17.11
EBITDA, 3 Yr. CAGR %	-	-	29.59	6.77	14.19
EBITA, 3 Yr. CAGR %	-	-	29.69	5.68	12.93
EBIT, 3 Yr. CAGR %	-	-	29.26	2.6	10.6
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	33.51	7.44	14.52
Net Income, 3 Yr. CAGR %	-	-	35.32	7.55	14.77
Normalized Net Income, 3 Yr. CAGR %	-	-	32.07	3.41	12.08
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	35.32	7.55	14.71
Accounts Receivable, 3 Yr. CAGR %	-	-	20.8	2.77	36.9
Inventory, 3 Yr. CAGR %	-	-	28.95	18.56	9.49
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	12.49	17.4	16.37
Total Assets, 3 Yr. CAGR %	-	-	30.54	24.18	23.36
Tangible Book Value, 3 Yr. CAGR %	-	-	15.37	18.05	17.93
Common Equity, 3 Yr. CAGR %	-	-	29.67	28.73	25.63
Cash From Operations, 3 Yr. CAGR %	-	-	15.28	19.14	23.7
Capital Expenditures, 3 Yr. CAGR %	-	-	16.02	51.26	1.07
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-1.84	27.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-1.29	27.59
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	15.72
Gross Profit, 5 Yr. CAGR %	-	-	-	-	16.79
EBITDA, 5 Yr. CAGR %	-	-	-	-	22.08
EBITA, 5 Yr. CAGR %	-	-	-	-	21.52
EBIT, 5 Yr. CAGR %	-	-	-	-	19.87
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	26.04
Net Income, 5 Yr. CAGR %	-	-	-	-	27.02
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	22.91
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	26.99
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	30.96
Inventory, 5 Yr. CAGR %	-	-	-	-	13.6
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	13.33
Total Assets, 5 Yr. CAGR %	-	-	-	-	23.81
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	22.58
Common Equity, 5 Yr. CAGR %	-	-	-	-	27.1
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	29.09
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	1.16